Fulgent Genetics Inc
General ticker "FLGT" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $586.5M
Fulgent Genetics Inc does not follow the US Stock Market performance with the rate: -25.0%.
Estimated limits based on current volatility of 1.8%: low 18.23$, high 18.90$
Factors to consider:
- US accounted for 97.4% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [21.90$, 45.46$]
- 2023-12-31 to 2024-12-30 estimated range: [17.60$, 37.02$]
Financial Metrics affecting the FLGT estimates:
- Positive: Non-GAAP EPS, $ of 5.70 > 2.29
- Positive: Operating cash flow per share per price, % of 24.96 > 12.76
- Negative: Industry operating cash flow per share per price (median), % of 1.95 <= 3.85
- Positive: Operating profit margin, % of 28.84 > 19.51
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.38 > 7.10
- Negative: Industry operating profit margin (median), % of -1.05 <= 2.14
- Negative: 0 < Industry inventory ratio change (median), % of 0
Short-term FLGT quotes
Long-term FLGT plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $417.36MM | $996.32MM | $618.97MM |
| Operating Expenses | $127.20MM | $320.37MM | $440.44MM |
| Operating Income | $290.16MM | $675.95MM | $178.53MM |
| Non-Operating Income | $1.53MM | $1.35MM | $5.50MM |
| R&D Expense | $11.58MM | $24.22MM | $28.91MM |
| Income(Loss) | $291.68MM | $677.30MM | $184.03MM |
| Taxes | $72.53MM | $174.79MM | $42.10MM |
| Other Income(Loss) | $-0.49MM | $0.00MM | $1.48MM |
| Profit(Loss) | $218.66MM | $502.50MM | $143.40MM |
| Stockholders Equity | $569.39MM | $1,158.75MM | $1,266.68MM |
| Inventory | $16.49MM | $12.21MM | $4.28MM |
| Assets | $700.46MM | $1,278.72MM | $1,386.05MM |
| Operating Cash Flow | $140.63MM | $538.58MM | $253.52MM |
| Capital expenditure | $36.51MM | $23.84MM | $18.77MM |
| Investing Cash Flow | $-326.44MM | $-546.55MM | $-261.31MM |
| Financing Cash Flow | $261.25MM | $85.39MM | $-77.14MM |
| Earnings Per Share* | $9.64 | $17.13 | $4.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.